| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| July 4th, 2006 | 32 | Yes |
Popular Name: Tobramycin Tobramycin
Find On: PubMed — Wikipedia — Google
CAS Numbers: 32986-56-4 , 79645-27-5 , [79645-27-5]
3'-Deoxykanamycin B; 32986-56-4; C00397; Nebramycin factir 6; Tobramycin
3'-Deoxykanamycin B;SPRC-AB01;Tobramycin solution for inhalation;Tobramycin Sulfate
32986-56-4; D00063; TOB; Tobracin (TN); Tobramycin (JP16/USP); Tobrex (TN)
79645-27-5; D02542; Nebcin (TN); Tobramycin sulfate (USP)
CHEBI:45933; CHEBI:9610; CHEBI:19849
CPD000058793; SAM001246911; TOBRAMYCIN
FLUOROMETHOLONE ACETATE; LS-187960; TOBRAMYCIN; TOBRASONE
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | -5.70 | -18.36 | -415.88 | 20 | 14 | 5 | 276 | 472.56 | 6 | ↓ |
| Hi High (pH 8-9.5) | -5.70 | -19.41 | -127.49 | 17 | 14 | 2 | 271 | 469.536 | 6 | ↓ |
| Hi High (pH 8-9.5) | -5.70 | -19.38 | -111.17 | 17 | 14 | 2 | 271 | 469.536 | 6 | ↓ |
| Mid Mid (pH 6-8) | -5.70 | -18.66 | -304.45 | 19 | 14 | 4 | 275 | 471.552 | 6 | ↓ |
| Mid Mid (pH 6-8) | -5.70 | -18.77 | -323.19 | 19 | 14 | 4 | 275 | 471.552 | 6 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| ALOGPS_SOLUBILITY | 5.37e+01 g/l | DrugBank-approved |
| UniProt Database Links | AAC2_MYCFO; AAC31_SALSP; AAC32_SALSP; AAC3_SERMA; AAC6C_SERMA; AAC6_ACIBA; AAC6_ACIG1; AAC6_ACIHA; AAC6_CITKO; AAC6_MORMO; AAC6_SALEN; AAC6_STEMA; AACA_ENTFA; AACA_ENTFC; AACA_STAAM; AACA_STAAU; AACA_STAEQ; AACA_STAHJ; AACA_STASC; AACA_STAWA; AACC2_ACIBA | ChEBI |
| Therapy | antibacterial, inhibits protein synthesis | SMDC MicroSource |
| Indications | antibiotic | KeyOrganics Bioactives |
| PUBCHEM_PATENT_ID | EP0000380A1; EP0000392A2; EP0000800A1; EP0001567A1; EP0001643A2; EP0004925A1; EP0005956A1; EP0007690A1; EP0009197A1; EP0009670A1; EP0016906A1; EP0017908A1; EP0025495A1; EP0025698A2; EP0025912A1; EP0027258A1; EP0032286A2; EP0034347A2; EP0037814A1; EP003869 | IBM Patent Data |
| Patent Database Links | EP1452533; EP1459763; EP1537861; EP1588702; EP1598059; EP1607103; EP1611877; EP1671624; EP1681065; EP1683526; EP1754712; EP1839648; EP1847256; EP1849463; EP1849797; EP1938822; EP1958956; EP1990639; EP1994930; US2003105066; US2005009921; US2005038008; US20 | ChEBI |
| PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Sigma Chemical Company; NCC_SUPPLIER_STRUCTURE_ID : T4014 | NIH Clinical Collection via PubChem |
| PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Sigma Chemical Company; SUPPLIER_STRUCTURE_ID: T4014 | NIH Clinical Collection via PubChem |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| Z100263-1-O | Ribosomal RNA A-site (cluster #1 Of 1), Other | Other | 1500 | 0.25 | Binding ≤ 10μM |
| Q77YF8-1-V | Human Immunodeficiency Virus Type 1 REV (cluster #1 Of 1), Viral | Viruses | 4110 | 0.24 | Functional ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| Z100263 | Z100263 | Ribosomal RNA A-site | 1500 | 0.25 | Binding ≤ 10μM |
| Q77YF8_9HIV1 | Q77YF8 | Human Immunodeficiency Virus Type 1 REV, 9hiv1 | 4110 | 0.24 | Functional ≤ 10μM |
